New Results
The development and characterization of an scFv-Fc fusion based gene therapy to reduce the psychostimulant effects of methamphetamine abuse
Charles E. Hay, Laura E. Ewing, Michael D. Hambuchen, Shannon M. Zintner, Juliana C. Small, Chris T. Bolden, William E Fantegrossi, Paris Margaritis, S. Michael Owens, View ORCID ProfileEric C. Peterson
doi: https://doi.org/10.1101/687129
Charles E. Hay
1University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.
Laura E. Ewing
1University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.
Michael D. Hambuchen
1University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.
Shannon M. Zintner
2The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.
Juliana C. Small
2The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.
Chris T. Bolden
1University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.
William E Fantegrossi
1University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.
Paris Margaritis
2The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.
3The Raymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, U.S.A.
4Department of Pediatrics, The University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, U.S.A.
S. Michael Owens
1University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.
Eric C. Peterson
1University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.
Article usage
Posted June 29, 2019.
The development and characterization of an scFv-Fc fusion based gene therapy to reduce the psychostimulant effects of methamphetamine abuse
Charles E. Hay, Laura E. Ewing, Michael D. Hambuchen, Shannon M. Zintner, Juliana C. Small, Chris T. Bolden, William E Fantegrossi, Paris Margaritis, S. Michael Owens, Eric C. Peterson
bioRxiv 687129; doi: https://doi.org/10.1101/687129
The development and characterization of an scFv-Fc fusion based gene therapy to reduce the psychostimulant effects of methamphetamine abuse
Charles E. Hay, Laura E. Ewing, Michael D. Hambuchen, Shannon M. Zintner, Juliana C. Small, Chris T. Bolden, William E Fantegrossi, Paris Margaritis, S. Michael Owens, Eric C. Peterson
bioRxiv 687129; doi: https://doi.org/10.1101/687129
Subject Area
Subject Areas
- Biochemistry (11561)
- Bioengineering (8622)
- Bioinformatics (28861)
- Biophysics (14793)
- Cancer Biology (11918)
- Cell Biology (17159)
- Clinical Trials (138)
- Developmental Biology (9302)
- Ecology (14019)
- Epidemiology (2067)
- Evolutionary Biology (18128)
- Genetics (12144)
- Genomics (16615)
- Immunology (11706)
- Microbiology (27689)
- Molecular Biology (11384)
- Neuroscience (60089)
- Paleontology (447)
- Pathology (1847)
- Pharmacology and Toxicology (3183)
- Physiology (4878)
- Plant Biology (10276)
- Synthetic Biology (2849)
- Systems Biology (7289)
- Zoology (1618)